TRIBUTE - A phase III trial of erlotinib HCl (OSI-774) combined with carboplatin and paclitaxel (CP) chemotherapy in advanced non-small cell lung cancer (NSCLC) - Concepedia

Concepedia

Publication | Closed Access

TRIBUTE - A phase III trial of erlotinib HCl (OSI-774) combined with carboplatin and paclitaxel (CP) chemotherapy in advanced non-small cell lung cancer (NSCLC)

131

Citations

0

References

2004

Year

Roy S. Herbst, Diane Prager, Róbert Hermann, V.A. Miller, Louis Fehrenbacher, P C Hoffman, Bruce E. Johnson, Alan B. Sandler, R. Mass, David H. Johnson

Journal of Clinical Oncology

Abstract

7011